Digital Detox Study
NCT06910371 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 200
Last updated 2025-04-04
Summary
The Digital Detox study is designed as a randomized controlled trial (two unblinded parallel groups) to examine the effects of reducing smartphone screentime on mental health. After giving informed consent, participants will be screened for eligibility. Inclusion criteria are adult subjects (greater-equal 18 years) using their smartphone daily for 3 hours or more, with sufficient German skills and no ongoing psychotherapy, psychological or psychopharmacological treatment. For eligibility screening, participants have to upload a screenshot of their smartphone screen time of the last week, have to state about mental health disorders (self-report) and their sociodemographic variables (age, gender, country of residence, education and professional status, urban/rural nature of place of residence), and have to fill out the following questionnaires: depressive symptoms (PHQ-9), well-being (WHO-5), sleep quality (ISI), stress (PSQ-20), loneliness (three-item loneliness scale), physical activity, and smartphone usage behavior.
If the inclusion criteria are met, participants will be randomized to the intervention or control group. The intervention consists of a three-week screen time reduction to a maximum of 2 hours per day for 3 consecutive weeks. The control group continues to use their smartphones as usual during this time. At the beginning of the study (=baseline T0), all participants will complete the following primary outcome measures (depressive symptoms (PHQ-9), well-being (WHO-5), sleep quality (ISI), stress (PSQ-20)) and secondary outcome measures (loneliness (three-item loneliness scale), craving (CEQ-F), physical activity). Both groups will also complete items on loneliness and physical activity twice during the intervention (after the first and second week of the intervention) to monitor changes in these variables during the intervention. After the three weeks of intervention (post-intervention T1), both groups will again fill out the the same outcome measures as for T0. After the 3-week intervention, there are no further restrictions regarding the participants' smartphone screen time. Follow-up (T2) will be after 3 more weeks and the same outcome measures as for T0 and T1 will be collected.
The weekly smartphone screen time is assessed via self-reporting and screenshot upload. Information is also provided on the weekly activations of the smartphone and a screenshot is uploaded of the most frequently used apps. All data is collected weekly for the previous week.
The study will be performed entirely via a smartphone app (ESMIra), which is designed especially to run longitudinal studies.
Primary hypotheses:
* H1: Reducing smartphone use to a maximum of 2 hours/day over 3 weeks leads to a difference in the depressive symptoms of the intervention participants before and after participating in the intervention.
* H2: Reducing smartphone use to a maximum of 2 hours/day over 3 weeks leads to a difference in the the sleep quality of the intervention participants before and after participating in the intervention.
* H3: Reducing smartphone use to a maximum of 2 hours/day over 3 weeks leads to a difference in perceived stress of the intervention participants before and after participating in the intervention.
* H4: Reducing smartphone use to a maximum of 2 hours/day over 3 weeks leads to a difference in the well-being of the intervention participants before and after participating in the intervention.
* H5: The reduction in smartphone use to a maximum of 2 hours/day over 3 weeks led to a difference in depressive symptoms between the control and intervention groups at the post-intervention time point.
* H6: The reduction in smartphone use to a maximum of 2 hours/day over 3 weeks led to a difference in sleep quality between the control and intervention groups at the post-intervention time point.
* H7: The reduction in smartphone use to a maximum of 2 hours/day over 3 weeks led to a difference in perceived stress between the control and intervention groups at the post-intervention time point.
* H8: The reduction in smartphone use to a maximum of 2 hours/day over 3 weeks led to a difference in well-being between the control and intervention groups at the post-intervention time point.
Conditions
- Prevention
- Digital Health
- Smartphone Addiction
Interventions
- BEHAVIORAL
-
smartphone screen time reduction
Smartphone screen time has to be reduced to less-equal 2 hours per day for 3 consecutive weeks.
Sponsors & Collaborators
-
Danube University Krems
lead OTHER
Principal Investigators
-
Christoph Pieh, Full Professor · University for Continuing Education Krems
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2025-03-31
- Primary Completion
- 2025-05-19
- Completion
- 2025-06-09
More Related Trials
-
The Effectiveness of a Smartphone Application in the Treatment of Alcohol Use Disorder
NCT03396887 ·Status: UNKNOWN ·Phase: NA
-
Cognitive Dysfunction in the Addictions Study - Project 4 (P4)
NCT06299787 ·Status: RECRUITING ·Phase: NA
-
Learning to Resist the Urge: Inhibition Training in Abstinent Patients With Alcohol Use Disorders
NCT02968537 ·Status: COMPLETED ·Phase: NA
-
Orexin Receptor Antagonism for the Treatment of Alcohol Use Disorder and Stress-Related Drinking
NCT07214207 ·Status: RECRUITING ·Phase: PHASE2
-
Study of Tirzepatide for Recovery and Alcohol Use Management
NCT06727331 ·Status: RECRUITING ·Phase: PHASE2
-
Guanfacine to Reduce Relapse Risk in Women With Alcohol Use Disorder (AUD)
NCT03137082 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Ketamine for the Rapid Treatment of Major Depressive Disorder and Alcohol Use Disorder
NCT02461927 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
An Internet-based Intervention for Problem Drinking
NCT00367575 ·Status: COMPLETED ·Phase: NA
-
Dronabinol Treatment for Marijuana Addiction
NCT00217971 ·Status: COMPLETED ·Phase: PHASE2
-
Mindfulness Meditation for Health
NCT01056484 ·Status: COMPLETED ·Phase: PHASE2
-
Varenicline for Alcohol Dependence
NCT01146613 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Evaluate AD04 in Adults With Alcohol Use Disorder (AUD) and Selected Serotonin Transporter Polymorphisms
NCT04101227 ·Status: COMPLETED ·Phase: PHASE3
-
Effectiveness Study of Dronabinol and BRENDA for the Treatment of Cannabis Withdrawal
NCT00480441 ·Status: COMPLETED ·Phase: PHASE2
-
High-dose Accelerated Theta Burst Stimulation for the Treatment of Alcohol Addiction
NCT05738174 ·Status: RECRUITING ·Phase: NA
-
The Effect of Melatonin Upon Post-Acute Withdrawal Among Males in a Residential Treatment Program
NCT02431728 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Screens, Virtual Reality and Digital Addiction (EVADD)
NCT05860660 ·Status: COMPLETED
-
Evaluation of the Efficacy of Sodium Oxybate in the Long-term Maintenance of Abstinence in Alcoholic Patients
NCT04648423 ·Status: COMPLETED ·Phase: PHASE4
-
Interest of tDCS in Help for Supporting Alcohol Abstinence
NCT03287154 ·Status: COMPLETED ·Phase: NA
-
Emergency Department-Initiated Medications for Alcohol Use Disorder
NCT05827159 ·Status: RECRUITING ·Phase: PHASE3
-
Combining a Smartphone App With Medications to Manage Heavy Drinking
NCT06303778 ·Status: RECRUITING ·Phase: NA
-
Inpatient Alcohol Detox & Psychotherapy
NCT03988478 ·Status: COMPLETED ·Phase: NA
-
Modification of Inhibitory Control and Craving Through Transcranial Direct Current Stimulation (tDCS) as an Add-On Treatment for Substance Use Disorder
NCT06959342 ·Status: RECRUITING ·Phase: NA
-
Soberlink Within In-Home Addiction Treatment Program
NCT03902171 ·Status: UNKNOWN
-
Evaluating the Effectiveness of Mobile Self-guided Psychological Interventions to Reduce Relapse in Substance Use Disorder
NCT05730504 ·Status: UNKNOWN ·Phase: NA
-
Working Memory Training in Adults With Substance Abuse and Executive Function Deficits.
NCT02068261 ·Status: UNKNOWN ·Phase: PHASE2